Cancer and the Combination Approach

Rhea-AI Summary

Jazz Pharmaceuticals, led by Liz Henderson, focuses on innovating oncology drug manufacturing to address supply chain issues in the pharmaceutical industry. The company emphasizes the importance of reliable drug supply for effective treatments in oncology.

Oncology is a tricky sector in which to innovate, but we can start by optimizing existing combination approaches

NORTHAMPTON, MA / ACCESSWIRE / March 28, 2024 / Jazz Pharmaceuticals

By Liz Henderson

Liz Henderson, Sr. Vice President Technical Operations at Jazz Pharmaceuticals discusses pioneering innovation in oncology and the importance of the manufacturing infrastructure to help achieve drug development goals.

Originally published by the Medicine Maker

Historically, innovation in the pharmaceutical industry has centered around the discovery of active pharmaceutical ingredients. A new, potentially life-saving treatment, however, can only make a difference if physicians can access a reliable supply. Drug shortages in oncology are not new. The global COVID-19 pandemic saw an increase in critical supply chain issues in the manufacture of drugs, which even further underscored the need for continued advancements in the manufacturing of oncology medicines.

Continue reading here

Credit: Author supplied

View additional multimedia and more ESG storytelling from Jazz Pharmaceuticals on 3blmedia.com.

Contact Info:
Spokesperson: Jazz Pharmaceuticals
Website: https://www.3blmedia.com/profiles/jazz-pharmaceuticals
Email: info@3blmedia.com

SOURCE: Jazz Pharmaceuticals

View the original press release on accesswire.com

FAQ

What sector does Jazz Pharmaceuticals focus on innovating in?

Jazz Pharmaceuticals focuses on innovating in the oncology sector.

Who is the Senior Vice President Technical Operations at Jazz Pharmaceuticals?

Liz Henderson is the Senior Vice President Technical Operations at Jazz Pharmaceuticals.

What is the primary focus of Jazz Pharmaceuticals in drug development?

Jazz Pharmaceuticals emphasizes the importance of manufacturing infrastructure to achieve drug development goals.

What issues in drug manufacturing did the global COVID-19 pandemic highlight?

The global COVID-19 pandemic highlighted critical supply chain issues in the manufacture of drugs, particularly in oncology.

Where can the original press release be viewed?

The original press release can be viewed on accesswire.com.